Gastric Cancer Registry makes unique contribution to research

New Report on Gastric Cancer Registry as Unique Resource for Research

The foundation launched the Gastric Cancer Registry in 2011 to create a bridge between patients and researchers who are working to discover improved diagnostics and treatments. A paper recently published by the American Association for Cancer Research reports on the Registry's unique contribution and its potential to accelerate collaborative gastric cancer research across the United States and the world.

We urge all patients and immediate family members to enroll in the Registry to help advance the search for better treatments and a cure.

Read Paper Here

Enroll in the Registry

Applications Open for Research Scholar Award

Applications are now being accepted for the GCF-AGA Ben Feinstein Memorial Research Scholar Award in Gastric Cancer. This award provides $100,000 per year for three years (totaling $300,000) to early career faculty working toward an independent career in gastric cancer research.

This award was established to enable outstanding investigators to launch new studies and build portfolios of work leading to competitive applications for larger grants.

Application Details

Read About Our Scholars

Gesundheit Superfoods: Fish

Calling all Salmon lovers! Chef Hans Rueffert will tell you that this cold water fish is the star of the superfoods. Listen to Hans and Dr. Ellen Steinberg discuss the many amazing omegas and vitamins available in fish, then enjoy a quick salmon salad on avocado toast. Give it a try and let us know what you think!

Watch the Video

Research Roundup

Several new developments in the treatment of gastric cancer have been reported in recent months, including:

The FDA granted fast-track designation to an antibody-drug conjugate from Keymed Biosciences that targets Claudin 18.2 (CLDN18.2) for the treatment of some patients with gastric cancer. Claudin 18.2 is a molecule found widely in solid tumors, including gastric cancer, and the drug is in early clinical trials.

Researchers in China took a different approach to CLDN18.2, developing a CAR-T cell therapy to target it in tumors. The experimental CAR-T showed early promise in an early clinical trial, shrinking gastric tumors in half of patients, they reported in the journal Nature Medicine.

Trishula Therapeutics announced positive initial results from a phase one trial of its anti-CD39 antibody, TTX-030, with an investigational anti-PD1 treatment and the chemotherapy regimen Folfox in gastric cancer.

More Research News

ICYMI: Gastric Cancer Treatment Advances

Gastric Cancer Foundation and CancerCare partnered again in June for the online workshop, “Gastric Cancer: Treatment Advances.” You can listen to the recording or watch the webcast at any time.

Watch the Webcast

Quick Links to Resources

JOIN THE REGISTRY

FIND CLINICAL TRIALS

OUR ONLINE COMMUNITY

Special Thanks to Our

National Sustaining Sponsors

Spread the word. Share the Gastric Cancer Foundation Newsletter.

DONATE